References
- 1. International Diabetes Federation (2019) Diabetes Atlas. 9th ed.
- 2. Kryzhevskyi Y., Bilyayeva O., Rykov S. et al. (2021) Study of new pathogenetic mechanisms of diabetic retinopathy development in patients with diabetic foot syndrome. J. Educat. Health Sport, 11(04): 233–246. DOI dx.doi.org/10.12775/JEHS.2021.11.04.024.
- 3. Biliaieva O.O., Rybianets Yu.V., Kryzhevskyi Ye.le. (2017) Porivnialna otsinka mistsevoho likuvannia hniino-nekrotychnykh uskladnen pry syndromi diabetychnoi stopy za dopomohoiu aplikatsiinykh sorbentiv. Suchasn. med. tekhnol., 4(35): 9–12 (In Ukr.).
- 4. Sibbald R., Ayello E. (2018) The Reduction of Diabetic Foot Amputations Starts with Preventing Foot Ulcers. Adv. Skin Wound Care, 31(9): 389. DOI: 10.1097/01.ASW.0000544473.65179
- 5. Prystupiuk O.M. (2002) Oksydantnyi stres za naiavnosti tsukrovoho diabetu. UMJ, 3(29): 23–25.
- 6. Bolotova D.G., Lobanov S.L., Morozov E.Ju. (2007) Analiz lechenija gnojno-nekroticheskih form sindroma diabeticheskoj stopy. Bjul. VSNC SO RAMN, 4: 38–39.
- 7. Bregovskij V.B., Zajcev A.A., Zelevskaja A.G. (2004) Porazhenie nizhnih konechnostej pri saharnom diabete. Medicina, 354 s.
- 8. Kozlov V.I. (2003) Gistofiziologiya sistemy mikrocirkulyacii. Regionarnoe krovoobrashchenie i mikrocirkulyaciya, 4: 79–85.
- 9. Pereira M.A., Sanomiya P., Leme J.G. (1987) Inhibition of leukocyte chemotasis by factor in alloxan-induced diabetic rat plasma. Diabete, 36(8): 1307–1314.
- 10. Kryzyna O.V. (2018). Patomorfologichni osoblyvosti krovopostachannja m’jakyh tkanyn nyzhnih kincivok pry cukrovomu diabeti. Visn. probl. biol. med., 4(1): 20–24.
- 11. Lankin V.Z., Tikhaze A.K., Belenkov Yu.N. (2000) Free radical processes in diseases of the cardiovascular system. Cardiology, 40(7): 48–61 (In Rus.).
- 12. Shih E.V., Petunina N.A., Nedosugova L.V. et al. (2020) Spontannaja i inducirovannaja sekrecija provospalitel’nyh i protivovospalitel’nyh citokinov u pacientov s saharnym diabetom 2 tipa i sindromom diabeticheskoj stopy. Saharnyj diabet, 23(3): 210–222 (In Rus.).
- 13. Kulinskij V.I. (1999) Aktivnye formy kisloroda i oksidativnaya modifikaciya makromolekul: pol’za, vred i zashchita. Sorosovskij obrazovatel’nyj zhurnal, 1: 2–7.
- 14. Anderson M.E. (1989) Enzymatic and chemical methods for the determination of glutathione. Glutathion, pt A.: 339–366.
- 15. Tsunada S., Iwakiri R., Noda T. et al. (2003) Chronic exposure to subtoxic levels of peroxidized lipids suppresses mucosal cell turnover in rat small intestine and reversal by glutathione. 48(1): 210–222. doi: 10.1023/a:1021775524062
- 16. Meister A., Anderson M.E. (1983) Glutathione. Ann. Rev. Biochem., 52: 711–760. doi: 10.1146/annurev.bi.52.070183.003431.
- 17. Kulinskij V.I., Kolesnichenko L.S. (2009) Sistema glutationa 1. Sintez, transport glutationtransferazy, glutationperoksidazy. Biomed. himiya, 55(3): 255–277 (In Rus.).
- 18. Deneke S.M., Fanburg B.Y. (1989) Regulation of cellular glutathione. Am. J. Physiol., 257(4 Pt. 1): 163–173. doi: 10.1152/ajplung.1989.257.4.L163.
- 19. Sies H., Graf P. (1985) Hepatic thiol and glutathione efflux under the influence of vasopressin, phenylephrine and adrenaline. Biochem. J., 226(2): 545–549. doi: 10.1042/bj2260545
- 20. Meggitt B. (1976) Surgical management of the diabetic foot. Br. J. Hosp. Med., 16: 227–332.
- 21. Wagner F. (1979) A classification and treatment program for diabetic, neuropathic, and dysvascular foot problems. Instr. Course Lect., 28(1): 143–165.
- 22. Monteiro-Soares M., Boyko E., Jeffcoate W. et al. (2020) Diabetic foot ulcer classifications: A critical review. Diabetes Metab. Res. Rev., 36 Suppl. 1: e3272. doi: 10.1002/dmrr.3272
- 23. American Diabetes Association (2003) Peripheralarterial disease in people with diabetes. Diabetes Care, 26: 3333–3341. DOI: 10.2337/diacare.26.12.3333.
- 24. Selyutina S.N., Selyutin A.Y., Pal A.I. (2000) Modification of the determination of the concentration of TBA-active products of blood serum. Klin. lab. Diagnostics, 2: 8–11.
- 25. Kostjuk V. A., Potapovich A. I., Kovaleva Zh. V. (1990) Prostoj i chuvstvitel’nyj metod opredelenija aktivnosti superoksiddismutazy, osnovannyj na reakcii okislenija kvercetina. Voprosy medicinskoj himii, 36(2): 88–91 (In Rus.).
- 26. Vanin A.F. (1998) Dinitrozil’nye kompleksy zheleza i S-nitrozotioly — dve vozmozhnye formy stabilizacii i transporta oksida azota v biosistemah. Biohimija, 63(7): 924–938 (In Rus.).
- 27. Jourd’heuil D., Hallén K., Feelisch M., Grisham M.B. (2000) Dynamic state of S-nitrosothiols in human plasma and whole blood. Free Radic. Biol. Med., 28(3): 409–417. doi: 10.1016/s0891-5849(99)00257-9.
- 28. Koval’chuk L.V. i dr. (2010) Immunologija: praktikum. GJeONTAR-media, 176 s. (In Rus.).
- 29. Dedov I.I., Udovichenko O.V., Galstyan G.R. (2005) Diabeticheskaya stopa. Prakt. Medicina, 197 s. (In Rus.).